Occurrence and significance of gastric colonization during acid-inhibitory therapy.
about
Airway cellularity, lipid laden macrophages and microbiology of gastric juice and airways in children with reflux oesophagitisEvaluation of the Antibacterial Potential of Liquid and Vapor Phase Phenolic Essential Oil Compounds against Oral MicroorganismsEffect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding.Epidemiology of Clostridium difficile infectionUse of proton pump inhibitors and H2 blockers and risk of pneumonia in older adults: a population-based case-control study.The role of protein digestibility and antacids on food allergy outcomes.Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.Clostridium difficile: improving the prevention paradigm in healthcare settings.Polymicrobial interactions: impact on pathogenesis and human disease.Gastric juice: a barrier against infectious diseases.Bile acids and Barrett's oesophagus: a sine qua non or coincidence?Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.Etiology and Risk Factors of Acute Gastroenteritis in a Taipei Emergency Department: Clinical Features for Bacterial Gastroenteritis.Microbial biofilms in the human gastrointestinal tract.Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.Community-acquired Clostridium difficile infection: an increasing public health threat.Risk factors for Clostridium difficile infection in surgical patients hospitalized in a tertiary hospital in Belgrade, Serbia: a case-control studyBarrett's esophagus: proton pump inhibitors and chemoprevention I.Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis.The importance of the gut microbiota after bariatric surgery.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Bile acid at low pH reduces squamous differentiation and activates EGFR signaling in esophageal squamous cells in 3-D culture.Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.Factors Predicting Recurrence of Clostridium difficile Infection (CDI) in Hospitalized Patients: Retrospective Study of More Than 2000 Patients.Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection.Effect of pH on an in vitro model of gastric microbiota in enteral nutrition patients.Atopic dermatitis and the intestinal microbiota in humans and dogs.Critical care dysmotility: abnormal foregut motor function in the ICU/ITU patient.Predicting Clostridium difficile toxin in hospitalized patients with antibiotic-associated diarrhea.Gastric acid-suppressive therapy and community-acquired respiratory infections.Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection.Comparative role of antibiotic and proton pump inhibitor in experimental Clostridium difficile infection in mice.
P2860
Q24813054-560D87E4-4B95-4F66-86D0-035A6AFEDBC2Q28554375-D03354AF-2294-4612-9048-8EB2F9E23424Q33885166-58606D0D-096B-443A-A0E9-360F67CD6C3EQ34027474-58C12C70-D972-4CF4-A699-720DF7E8EFB0Q34124510-229591E2-C2D9-4EF2-95D3-F956EEF77076Q34394239-A2B54D08-E642-442F-A066-9126032D5AB3Q34549108-E3B0B014-2B86-4B00-880E-A73CA2E22A69Q35222472-C98D0CFA-7697-4EF6-B55F-EEC57C764098Q35666253-06CC53F9-41E0-40FB-B603-27FA83D871ECQ36023592-F2FB6AB1-104A-4B72-BAB6-48B26EA4BE34Q36510659-6057EECA-FB6C-4D96-949D-276A659DBF50Q36513062-04BC3AE9-8DB1-4F1C-BDCD-2A14A4EED215Q36731591-296FA039-8C48-46E1-B241-F7329BA8BC4CQ36797293-664F03F8-F27E-44C3-825A-865069819CE9Q37414672-AC5A9F44-DA6D-471E-9498-06677EC28F32Q37655456-ED76175C-2BB9-4FDB-B576-657294BD0E53Q37724361-6BD4AB88-C003-4170-83F7-B95FDB598BF0Q37939281-222072C6-9626-453A-AE34-6BFFBF8AFA5DQ38004673-52B7E682-7F2E-4163-8E8F-325462BBF135Q38038435-C51B84B2-42B0-413F-A110-D5A169A70886Q38865456-0696F166-7F04-4F39-A186-B0BFF3C23244Q39114318-663AB2CF-53D4-450B-8C3A-9D041D9FDA6FQ40272415-1407D66C-41D3-4B21-A069-47F331C43EF9Q41076074-1234741D-0EF0-43CB-8A65-33CD10B91221Q41864070-F04740B1-1D17-4E06-881C-E74754EF67E2Q42132389-68A2D8DF-BC10-465B-9C3F-83186C72F296Q42682689-3BDAA938-EB7D-4B70-A0FD-3BA7187D6049Q43004209-1A647248-DDCF-4B01-B52E-D993C6E89F4FQ44586645-F6AD6A6F-814A-43A1-BF2F-78D1CC085E01Q44611999-D439A6FE-CF08-4FBD-AF97-29A61270BE04Q46796604-B199E1E0-230D-4D44-9911-D702948E61FFQ46840417-DA33E0BB-4D62-4455-9AB7-520EE96B6601
P2860
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@ast
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@en
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@nl
type
label
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@ast
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@en
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@nl
prefLabel
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@ast
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@en
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@nl
P356
P1476
Occurrence and significance of gastric colonization during acid-inhibitory therapy.
@en
P2093
Williams C
P304
P356
10.1053/BEGA.2001.0191
P577
2001-06-01T00:00:00Z